Cases & Deals

Share

Funds managed by Invesco invest in Cell Medica

March 2017

Client(s) Invesco Asset Management Limited

Jones Day advised Invesco Asset Management in connection with the purchase by its discretionary managed funds of Series C Convertible Preferred Stock in a private placement by Cell Medica, a leading cellular immunotherapy company. Touchstone Innovations and funds managed by Woodford Investment Management acted as co-investors in the investment round.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.